IP Library › Assignment 034116/0974
Patent Assignment
Reel/Frame 034116/0974

Corrective Assignment to Correct the Assignee and Assignor. Previously Recorded on Reel 033886 Frame 0313. Assignor(S) Hereby Confirms the Confirmatory Assignment.

Recorded: 2014-10-20 Pages: 15
Assignor
Assignees
NOVARTIS VACCINES AND DIAGNOSTICS, INC.
IP SERVICES BLDG. 433 257, ONE HEALTH PLAZA, EAST HANOVER, NEW JERSEY, 07936-1080
GRIFOLS WORLDWIDE OPERATIONS LIMITED
EMBASSY HOUSE, BALLSBRIDGE, DUBLIN 4, D4, IRELAND
Covered Properties (44)
Combinations of Hepatitis C Virus (Hcv) Antigens for Use in Immunoassays for Anti-Hcv Antibodies
Patent: 5,683,864 →
Application: 07/910,760 →
Nanbv Diagnostics: Polynucleotides Useful for Screening for Hepatitis C Virus
Patent: 5,714,596 →
Application: 08/040,564 →
Hiv Immunoassays Using Gag Polypeptides
Patent: 6,458,527 →
Application: 08/083,391 →
Hiv Immunoassays Using Synthetic Envelope Polypeptides
Patent: 7,273,695 →
Application: 08/089,407 →
Hepatitis C Virus Infected Cell Systems
Patent: 5,679,342 →
Application: 08/097,853 →
Genomic Sequences for Diagnostics and Therapeutics
Patent: 6,190,864 →
Application: 08/221,653 →
Immunoreactive Polypeptide Compositions
Patent: 5,756,312 →
Application: 08/231,368 →
Hepatitis C Virus Asialoglycoproteins
Patent: 6,274,148 →
Application: 08/249,843 →
A Vector for Expression of a Polypeptide in a Mammalian Cell
Patent: 5,688,688 →
Application: 08/288,336 →
Nanbv Diagnostics and Vaccines Polynucleotides Useful for Screening for Hepatitis C Virus
Patent: 6,074,816 →
Application: 08/307,273 →
Methods for Detecting Human Immunodeficiency Virus Nucleic Acid
Patent: 6,531,276 →
Application: 08/403,588 →
Nanbv Diagnostics and Vaccines
Patent: 6,346,375 →
Application: 08/403,590 →
Conserved Motif of Hepatitis C Virus E2/NS1 Region
Patent: 6,692,907 →
Application: 08/437,943 →
Hepatitis C Virus Infected Cell Systems
Patent: 5,968,775 →
Application: 08/438,435 →
Methods and Compositions for Controlling Translation of Hcv Proteins
Patent: 6,057,093 →
Application: 08/439,996 →
Immunoreactive Polypeptide Compositions
Patent: 5,670,152 →
Application: 08/440,103 →
Methods and Compositions for Controlling Translation of Hcv Proteins
Patent: 5,922,857 →
Application: 08/440,209 →
Ymmunoreactive Polypeptide Compositions
Patent: 5,766,845 →
Application: 08/440,210 →
Immunoassays for Anti-Hcv Antibodies Employing Combinations of Hepatitis C Virus (Hcv) Antigens
Patent: 5,712,087 →
Application: 08/440,519 →
Immunoreactive Polypeptide Compositions
Patent: 5,670,153 →
Application: 08/440,542 →
Hepatitis C Virus Protease
Patent: 5,597,691 →
Application: 08/440,548 →
Combinations of Hepatitis C Virus (Hcv) Antigens for Use in Immunoassays for Anti-Hcv Antibodies
Patent: 6,312,889 →
Application: 08/440,549 →
Nanbv Diagnostics and Vaccines
Patent: 6,027,729 →
Application: 08/440,755 →
Methods for Detecting Hepatitis C Virus Using Polynucleotides Specific for Same
Patent: 5,712,088 →
Application: 08/440,769 →
Cell Culture Systems for Hcv
Patent: 6,096,541 →
Application: 08/441,026 →
Nanbv Diagnostics and Vaccines
Patent: 7,790,366 →
Application: 08/441,443 →
Hcv Genomic Sequences for Diagnostics and Therapeutics
Patent: 6,297,370 →
Application: 08/441,970 →
Hcv Genomic Sequences for Diagnostics and Therapeutics
Patent: 6,071,693 →
Application: 08/441,971 →
Hcv Genomic Sequences for Diagnostics and Therapeutics
Patent: 6,214,583 →
Application: 08/442,144 →
Antibody Compositions to Hcv and Uses Thereof
Patent: 6,171,782 →
Application: 08/442,647 →
Human Immunodeficiency Virus (Hiv) Nucleotide Sequences, Recombinant Polypeptides, and Applications Thereof
Patent: 7,205,101 →
Application: 08/442,748 →
Recombinant Dna Constructs for Gag Polypeptides and Polypeptides Produced Thereby
Patent: 7,408,053 →
Application: 08/442,750 →
Recombinant Dna Construct for Hiv Envelope Polypeptides and Polypeptides Produced Thereby
Patent: 7,425,428 →
Application: 08/443,077 →
A Method for Expressing Hiv Polypeptides
Patent: 7,442,525 →
Application: 08/443,118 →
Purified Pol Dna, a Recombinant Dna Construct for Expression of Hiv Pol Polypeptide Sequences and a Cell Containing Such Construct
Patent: 7,527,925 →
Application: 08/443,433 →
Immunoassay of Hiv Antibodies Using Recombinant or Synthetic Selected Pol Sequence
Patent: 6,013,432 →
Application: 08/443,434 →
Nanbv Diagnostics and Vaccines
Patent: 6,150,087 →
Application: 08/444,818 →
Human Immunodeficiency Virus (Hiv) Nucleotide Sequences, Recombinant Polypeptides, and Applications Thereof
Patent: 7,285,271 →
Application: 08/456,024 →
Immunoreactive Polypeptide Compositions
Patent: 5,728,520 →
Application: 08/471,498 →
Method for Detecting Hepatitis C Virus Using Polynucleotides Specific for Same
Patent: 5,863,719 →
Application: 08/472,821 →
Bmethods and Compositions for Controlling Translation of Hcv Proteins
Patent: 7,018,984 →
Application: 08/477,895 →
Heteroduplex Tracking Assay (Hta) for Genotyping Hcv
Patent: 5,851,759 →
Application: 08/634,797 →
Novel Hepatitis C E1 and E2 Polypeptides and Methods of Obtaining the Same
Patent: 6,121,020 →
Application: 08/824,057 →
Human Immunodeficiency Virus (Hiv) Nucleotide Sequences
Patent: 41,158 →
Application: 12/352,068 →
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Aug 10, 2007
From: CHIRON CORPORATION
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 019684/0926 →
Merger Jan 27, 2011
From: CHIRON CORPORATION
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 025706/0431 →
First Lien Patent Security Agreement Sep 2, 2011
From: COMPOSITECH; SRAM LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026856/0464 →
Confirmatory Assignment Oct 2, 2014
From: NOVARTIS VACCINES AND DIAGNOSTICS, INC.; NOVARTIS AG
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.; NOVARTIS AG; GRIFOLS WORLDWIDE OPERATIONS LIMITED
Reel/Frame 033886/0313 →